Pregnancy Morbidity in Antiphospholipid Syndrome: What Is the Impact of Treatment?

Title
Pregnancy Morbidity in Antiphospholipid Syndrome: What Is the Impact of Treatment?
Authors
Keywords
Antiphospholipid syndrome, APS, Obstetric APS, Obstetric antiphospholipid syndrome, Pre-eclampsia, Intrauterine growth restriction, Prematurity, Treatment, Abortion, Pregnancy loss, Fetal death, Heparin, Aspirin, Complement activation, Thrombosis, Hydroxychloroquine, Eculizumab
Journal
Current Rheumatology Reports
Volume 16, Issue 2, Pages -
Publisher
Springer Nature
Online
2014-01-04
DOI
10.1007/s11926-013-0403-6

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation